MedPath

The M&M Trial: Evaluating micronutrients and mindfulness for emotional dysregulation in children: A community-based randomised placebo-controlled trial

Not Applicable
Conditions
Emotional dysregulation
Mental Health - Other mental health disorders
Registration Number
ACTRN12624000673549
Lead Sponsor
Professor Julia Rucklidge
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
160
Inclusion Criteria

1)Participants must meet criteria for emotional dysregulation as indicated by scores of 10 or more on the Emotion Dysregulation Inventory-Reactivity subscale (parent report) and an average score of 1 or more on the Parent-rated Affective Reactivity Index (ARI) and be assessed as moderate impairment by the Clinical Global Impression Severity (CGI-S),
2)Must be aged between 6 and 10 years of age,
3)Participants must have English competency sufficient to correctly interpret and complete study materials and questionnaires,
4)Must be medication free (psychiatric) for >4 weeks,
5)Be able to ingest 1 powder sachet per day,
6)Have at least one parent/caregiver/whanau member able to attend 6 weekly therapy sessions online with the child and access to the internet. To ensure the data collected are valid, it is important that the same parent/caregiver is available for reviews and sessions. This will be made clear in the consent meeting.

Exclusion Criteria

1)Any serious medical or psychiatric condition potentially requiring hospitalisation,
2)Known allergy to any of the Stick or Placebo ingredients, or known abnormality of mineral metabolism (e.g., Wilson’s disease, hemochromatosis),
3)Epilepsy and,
4)Any serious mental health or behavioural concerns for either parents or child that may interrupt their ability to engage with the online programme or compromise therapeutic learning (e.g., severe conduct disorder, low intellectual functioning, traumatic brain injury, pervasive developmental disorder, severe parental substance abuse or psychiatric disorder).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath